Previous Article | Next Article 
Journal of Virology, March 1999, p. 1998-2005, Vol. 73, No. 3
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Regulated Expression of a Sindbis Virus Replicon by
Herpesvirus Promoters
Lidia
Ivanova,
Sondra
Schlesinger, and
Paul D.
Olivo*
Department of Molecular Microbiology,
Washington University School of Medicine, St. Louis, Missouri
63110-1093
Received 12 October 1998/Accepted 4 December 1998
 |
ABSTRACT |
We describe the use of herpesvirus promoters to regulate the
expression of a Sindbis virus replicon (SINrep/LacZ). We isolated cell
lines that contain the cDNA of SINrep/LacZ under the control of a
promoter from a herpesvirus early gene which requires regulatory proteins encoded by immediate-early genes for expression. Wild-type Sindbis virus and replicons derived from this virus cause death of most
vertebrate cells, but the cells discussed here grew normally and
expressed the replicon and
-galactosidase only after infection with
a herpesvirus. Vero cell lines in which the expression of SINrep/LacZ
was regulated by the herpes simplex virus type 1 (HSV-1) infected-cell
protein 8 promoter were generated. One Vero cell line (V3-45N)
contained, in addition to the SINrep/LacZ cDNA, a Sindbis
virus-defective helper cDNA which provides the structural proteins for
packaging the replicon. Infection of V3-45N cells with HSV-1 resulted
in the production of packaged SINrep/LacZ replicons. HSV-1 induction of
the Sindbis virus replicon and packaging and spread of the replicon led
to enhanced expression of the reporter gene, suggesting that this type
of cell could be used to develop sensitive assays to detect
herpesviruses. We also isolated a mink lung cell line that was
transformed with SINrep/LacZ cDNA under the control of the promoter
from the human cytomegalovirus (HCMV) early gene UL45. HCMV
carries out an abortive infection in mink lung cells, but it was able
to induce the SINrep/LacZ replicon. These results, and those obtained
with an HSV-1 mutant, demonstrate that this type of signal
amplification system could be valuable for detecting herpesviruses for
which a permissive cell culture system is not available.
 |
INTRODUCTION |
Replicons derived from alphaviruses
such as Sindbis virus are well established as useful vectors for gene
expression (2, 3, 21, 36). We have been investigating the
potential use of the Sindbis virus replicon as a tool for detection of
other viruses, particularly those that grow to low titer and are not easily detected by plaque assay (27). We have also been
interested in establishing cell lines that can be induced to produce
functional Sindbis virus replicons. These two goals, detection of
viruses and induction of a replicon, led to the studies presented here, in which two members of the herpesvirus family were used to induce a
Sindbis virus replicon. Herpes simplex virus type 1 (HSV-1) is a member
of this family which is easily detected, but because it has been
well-characterized, it provided a useful model to test our concepts. In
contrast, human cytomegalovirus (HCMV), because it replicates slowly
and in a limited number of cell lines, is an example of a herpesvirus
for which a better detection assay could be valuable (39).
There are several features of the Sindbis virus genome and its
replication strategy that are important for understanding its development as a gene expression vector and its use in the systems to
be described here (37, 41). The positive-strand RNA genome consists of a sequence of approximately 12 kb that is divided into two
functional modules. The 5' two-thirds codes for the nonstructural proteins, and the 3' one-third codes for the structural proteins. In
the infected cell only the nonstructural proteins, which are required
for replication and transcription of the RNA, are translated from the
genomic RNA. The structural proteins are translated from a subgenomic
RNA that is colinear with the 3' one-third of the genome. The
structural proteins are not required for replication and transcription
of the genomic RNA. cDNAs of Sindbis virus replicons have been
genetically engineered by replacing genes for the structural proteins
with a heterologous gene (3, 11, 35, 43). Under conditions
in which the structural proteins are provided in trans by
means of a defective RNA containing these genes, the replicon genome is
packaged into virus-like particles (4). In the original studies, the engineered Sindbis virus cDNA was placed under the control
of the SP6 bacteriophage promoter, the DNA was transcribed in vitro,
and the RNA was transfected into susceptible cultured cells
(43). More recently, there have been several studies in which Sindbis virus replicon cDNAs or defective cDNAs have been transcribed from cellular RNA polymerase II promoters after
transfection of the DNA into cultured cells (9, 15, 16, 26,
29). Although it has been possible to obtain stable cell lines
containing defective Sindbis virus cDNAs under the control of
constitutive eukaryotic promoters (26), cells containing
intact Sindbis virus replicons under the control of such promoters
would not survive because expression of these replicons is cytopathic
in vertebrate cells (12).
The herpesviruses are a family of complex DNA viruses. The best-studied
member of this family is HSV-1, which has a 150-kb genome that contains
over 80 genes (32). Based on their temporal expression and
regulation during the viral replication cycle, HSV-1 genes are
classified into immediate-early (alpha), early (beta), and late (gamma)
genes (17), and this is dictated in part by their promoters.
We chose to use the promoter of the HSV-1 UL29 gene, which
encodes infected-cell protein 8 (ICP8), the HSV-1 major single-strand
DNA-binding protein (22, 31). The 5' end of the ICP8
transcript has been mapped (42). This allowed us to design a
DNA construct in which the cDNA of the Sindbis virus replicon was
linked to the HSV-1 ICP8 DNA promoter in such a way that transcription
from this chimeric gene yielded an RNA transcript with a 5' end
compatible with a functional replicon. Essential features of the gene
encoding ICP8 are that it is an early (beta) gene and that its
expression is dependent on the regulatory proteins encoded by HSV-1
immediate-early genes such as ICP0 and ICP4 (24, 30, 42).
For the HCMV studies, we also used a promoter from an early gene,
UL45, which encodes a homolog of the HSV-1 large subunit of
ribonucleotide reductase (6). Any gene under the control of
a herpesvirus early promoter is not likely to be expressed in the
absence of infection by the cognate herpesvirus. We describe our
results obtained by using this viral regulatory system to control
expression of a Sindbis virus replicon.
 |
MATERIALS AND METHODS |
Plasmids. (i) pICP8SINrep/LacZ.
The term ICP8 is used for
all references to the UL29 gene or its promoter because it
has been the more widely used designation. The ICP8 promoter sequence
was amplified from purified HSV-1 genomic DNA by PCR by using synthetic
oligonucleotides (DNAgency, Inc.) flanking this region. The primers
were 30- and 35-mer oligonucleotides (upstream primer, 5'-GTT TGT CTG
GCG GAT CCG GAC GGC GAG CTG-3'; downstream primer, 5'-CCA TGG CTC GAG
GTA TGC GGT TGG TAT ATG TAC AC-3'). The 5' and 3' termini contained
BspEI and XhoI sites, respectively, to facilitate
cloning. The amplification was done in 20 cycles by using KlenTaq-LA
enzyme (Wayne Barnes, Washington University, St. Louis, Mo.) in the
presence of 2.2 M betaine (Sigma, St. Louis, Mo.) under the following
conditions: 30 s at 94°C, 30 s at 60°C, and 1 min at
68°C. The PCR product was digested with BspEI and
XhoI, and the product was then cloned into NgoMI- and XhoI-digested pSINrep/LacZ by placing a XhoI
site at the 5' terminus of the cDNA of pSINrep/LacZ (4).
Plasmid and promoter identities were confirmed by restriction mapping
and nucleotide sequencing. Plasmid DNAs were purified on CsCl gradients
for use in transfections.
(ii) pUL45SINrep/LacZ and pUL45/LacZ.
The
HindIII M fragment of the HCMV (Towne strain) genome was
cloned into pBR322 to generate pCMHM. The UL45 promoter was
isolated from pCMHM as a 657-bp SmaI fragment, which was
cloned into pUC18. Finally, the UL45 promoter was cloned as
an XmaIII to XhoI fragment in front of
SINrep/LacZ cDNA or the lacZ gene to generate
pUL45SINrep/LacZ and pUL45/LacZ, respectively.
(iii) p987DHBBneo.
This plasmid was made from pDHBB, a
defective helper cDNA which contains the Sindbis virus structural
protein genes downstream of the subgenomic RNA promoter (4).
p987DHBBneo was constructed by positioning the cDNA of DHBB immediately
3' of the Rous sarcoma virus promoter and inserting an IRES
element-neo gene cassette downstream of the stop codon for
the structural proteins in the 3' nontranslated region of the DHBB
genome (further details are available on request).
Cells and viruses.
Baby hamster kidney (BHK-21) cells, Vero
cells (African green monkey kidney cells), and mink lung cells were
obtained from the American Type Culture Collection (ATCC, Manassas,
Va.) BHK cells were grown in alpha-minimum essential medium (
-MEM)
supplemented with 10% fetal bovine serum, nonessential amino acids,
100 U of penicillin/ml, and 100 µg of streptomycin/ml. Vero and mink
lung cells were propagated in Dulbecco's MEM (DMEM) containing 10% fetal bovine serum, 100 U of penicillin/ml, and 100 µg of
streptomycin/ml.
HSV-1 (KOS strain) was obtained from Mark Challberg (National
Institutes of Health, Bethesda, Md.). Stocks of HSV-1 were grown and
titered on Vero cells. HSV-1 mutant viruses d21 and
dlx3.1 were obtained from Priscilla Schaffer (University of
Pennsylvania), and d120 was obtained from Neal DeLuca
(University of Pittsburgh). HCMV strains (Towne and AD169 strains) were
obtained from Gregory Storch (Washington University). HCMV stocks were
grown on MRC5 cells (Diagnostic Hybrids, Inc., Athens, Ohio) and
titrated by an infectious foci assay by using indirect
immunofluorescence and monoclonal antibody to an immediate-early
antigen (Chemicon, Temecula, Calif.).
Transfection and selection of cell lines: (i)
ICP8SINrep/LacZ-transformed V2-33, V2-34, and V3-45 cells.
Subconfluent (50 to 60% confluence) Vero cells in 35-mm-diameter
dishes were transfected with pICP8SINrep/LacZ and a plasmid containing
the hygromycin B gene under control of the simian virus 40 promoter (pMonHygro; a gift of Paul Hippenmeyer, Monsanto, St. Louis,
Mo.) at a molar ratio of 5:1 or 10:1 by using 6 µl of Lipofectamine
in Opti-MEM (Life Technologies, Gaithersburg, Md.) according to the
manufacturer's recommendations at 37°C for 5 h, at which time
the media were changed to complete media. At 72 h posttransfection
cells were split 1:10 in selective media containing 500 µg of
hygromycin B/ml (Boehringer Mannheim, Indianapolis, Ind.), which were
then replaced every 3 days. After 3 weeks, individual colonies were
isolated and the hygromycin B concentration was reduced to 100 µg/ml.
(ii) ICP8SINrep/LacZ and helper cDNA doubly transformed V3-45N
cells.
The doubly transformed replicon/helper cell line was
isolated by transfecting V3-45 cells with p987DHBBneo by using 1 µg
of DNA plus 6 µl of Lipofectamine per 35-mm-diameter dish for 5 h at 37°C in Opti-MEM. Seventy-two hours posttransfection, the cells were seeded in selective media containing 100 µg of hygromycin/ml and
5 mg of G418 (Life Technologies) per ml. Once the nontransformed control cells were all killed, the G418 concentration was decreased to
1 mg/ml, and 2 weeks later it was decreased to 400 µg/ml. Individual colonies were isolated and expanded in media containing hygromycin B
(100 µg/ml) and G418 (400 µg/ml).
(iii) MLUL45SINrep/LacZ and MLUL45/LacZ cells.
These cell
lines were isolated by cotransfecting mink lung cells with
pUL45SINrep/LacZ (2 µg) and pMonHygro (0.1 µg) or pUL45/LacZ (1 µg) and pMonHygro (0.1 µg). Forty hours later the cells were treated with hygromycin B (500 µg/ml) for 7 days. After 3 weeks individual colonies were isolated, expanded in media containing hygromycin B (100 µg/ml), and evaluated for HCMV-inducible
-galactosidase.
RNA isolation.
MLUL45SINrep/LacZ cells (2 × 107 cells) were pretreated overnight with Turbotreat
reagent (a proprietary medium additive that enhances HCMV gene
expression in mink lung cells) (Diagnostic Hybrids, Inc.)
(38) and were either mock infected or infected with HCMV
(multiplicity of infection [MOI] of 2) in the presence of a 10-fold
dilution of Turbotreat reagent. Forty hours postinfection cells were
harvested on ice and resuspended in TRIZOL reagent (Life Technologies).
RNA was isolated according to the manufacturer's procedure.
Polyadenylated RNA was then isolated by chromatography on
oligodeoxyribosylthymine-cellulose or by immobilization on streptavidin
magnetic particles as recommended by the manufacturer (Boehringer
Mannheim). Three hundred sixty micrograms of total RNA and 6 to 12 µg
of poly(A) RNA were obtained from 2 × 107 cells.
-Galactosidase assays. (i) Colorimetric assay.
The
-galactosidase activity of cell extracts was measured by using the
substrate chlorophenol red-
-D-galactopyranoside (CPRG; Boehringer Mannheim) at a final concentration of 5 mM in a 0.2 M
potassium phosphate buffer, pH 7.8, with 1 mM MgCl2.
Extracts were made in this buffer containing 1% Triton X-100 and 1 mM
dithiothreitol. A sample of the extract (10 to 50 µl) was mixed with
50 µl of substrate in a microtiter plate well. After incubation for 1 to 2 h at room temperature, the optical density at a wavelength of 562 nM (OD562) was measured with a THERMOmax microplate
reader by using SOFTmax software (Molecular Devices, Sunnyvale,
Calif.). The OD562 of a control containing no extract was
subtracted from all sample values. The assay was shown to be linear up
to an OD562 of 3.0.
(ii) Histochemical staining.
Cell monolayers were washed one
time with 1 ml of phosphate-buffered saline (PBS, pH 7.2) and then
fixed in 2% formaldehyde and 0.4% glutaraldehyde in PBS for 5 min.
After they were washed twice with PBS, cells were incubated at room
temperature in staining solution (1 mg of
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside [X-Gal;
Sigma] per ml, 4 mM potassium ferricyanide, 4 mM potassium ferrocyanide, and 2 mM MgCl2 in PBS).
Titration of SINrep/LacZ.
SINrep/LacZ particles were
titrated by using the X-Gal histochemical stain and counting the number
of blue cells. Serial dilutions of a stock of SINrep/LacZ were
inoculated onto BHK cell monolayers in the wells (each 4 cm2) of 12-well dishes. Sixteen hours later the cells were
fixed and histochemically stained for
-galactosidase. The number of blue cells was determined, and this was then correlated with
OD562 readings from the colorimetric assay performed under
a standard set of conditions with extracts from cells infected in
parallel. The standard curve generated allowed us to determine the
infectious particle (packaged replicon) titer in samples of media
without the tedium of having to count cells under the microscope.
 |
RESULTS |
Induction of SINrep/LacZ by infection with HSV-1.
We have used
two criteria in these studies to demonstrate that SINrep/LacZ could be
induced by infection of cells with a herpesvirus. The first was
HSV-1-dependent
-galactosidase activity. Induction alone does not
establish that the replicon genome is intact and that translation of
-galactosidase is dependent on prior replication and transcription
of the replicon. The second, and essential, criterion was that
infectious, extracellular particles were produced when induction
occurred in the presence of a Sindbis virus defective helper that
provides the structural proteins for packaging.
SINrep/LacZ cDNA was placed under the control of the ICP8 promoter (see
Materials and Methods and Fig.
1). The cloning strategy
was designed to
place the previously mapped transcription start
site of the ICP8
promoter close to the 5' end of the replicon
(Fig.
1B). Before attempting to isolate
inducible cell lines,
we first asked if this construct was silent in
uninfected cells
and inducible by HSV-1. We tested both BHK cells and
Vero cells
in transient-transfection assays. Twenty-four hours after
transfection
with pICP8SINrep/LacZ the cells were infected with HSV-1,
and

-galactosidase activity was measured after 18 h by
histochemistry.
A few BHK cells stained positively for

-galactosidase in the
absence of infection with HSV-1, although the
number of stained
cells increased after infection. In contrast, Vero
cells showed

-galactosidase activity only after infection with HSV-1
and were
chosen for all further studies with HSV-1 (data not shown).

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 1.
ICP8 promoter/Sindbis replicon cDNA chimeric construct.
(A) Schematic diagram of ICP8SINrep/LacZ construct. The figure is not
drawn to scale. pro, promoter; SV, Sindbis virus; nsP,
nonstructural proteins; SG, subgenomic. The sequence shown in panel B
is located in the bracketed region. (B) Sequence of the junction of the
ICP8 promoter and the 5' terminus of the Sindbis virus replicon genome.
The arrow indicates the predicted start of transcription based on
mapping studies of the ICP8 transcript (42). Uppercase
nonboldface letters indicate HSV-1 sequences. Boldface letters indicate
Sindbis virus sequences. Lowercase letters indicate bases introduced
during cloning to create restriction sites BspEI and
XhoI (underlined).
|
|
These results did not establish that HSV-1 was able to induce
SINrep/LacZ in the Vero cells. It was possible that
lacZ
expression
occurred independently of replicon activity because HSV-1
had
been shown to transactivate a foreign gene even when the latter
was
placed within a defective Sindbis cDNA several kb downstream
of a
polymerase II promoter (
26). To determine if a functional
replicon was being transcribed in Vero cells, we included in the
transfection mixture a defective helper plasmid (p987DHBBneo;
described
in Materials and Methods) capable of packaging the replicon.
The
protocol was further modified by the addition of acyclovir
to block
HSV-1 DNA synthesis and HSV-1 production. The absence
of HSV-1 in the
supernatant fluids of the transfected Vero cells
made it possible to
detect packaged Sindbis virus replicons in
these samples without
cytopathic effects attributable to HSV-1
progeny. Samples of media
taken from variously treated Vero cells
were inoculated onto naive BHK
cells.

-Galactosidase-positive
BHK cells were detected only with
media obtained from Vero cells
that had been cotransfected with
pICP8SINrep/LacZ and p987DHBBneo
and infected with HSV-1. No
infectious particles capable of inducing

-galactosidase were
detected in mock-infected Vero cells, HSV-1-infected
Vero cells
transfected without the defective helper plasmid, or
HSV-1-infected
Vero cells cotransfected with the defective helper
plasmid and a
control plasmid, pICP8LacZ, which contains the
lacZ gene
directly downstream of the ICP8 promoter. (These data are
not shown,
but see Fig.
3 for similar results obtained with stable
cell lines.)
Isolation of a stable cell line of Vero cells with an
HSV-1-inducible SINrep/LacZ replicon.
pICP8SINrep/LacZ and a
plasmid carrying the gene for hygromycin B resistance (pMonHygro) were
cotransfected into Vero cells, which were then selected for hygromycin
B resistance (see Materials and Methods). A number of cell lines that
exhibited positive staining for
-galactosidase in most of the cells
only after infection with HSV-1 were selected. Cell extracts from three
clones (V2-33, V2-34, and V3-45) had activity dependent upon infection
of the cells with HSV-1 (data for V2-33 and V2-34 are shown in Fig.
2; data for V3-45 are not shown).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 2.
HSV-1-induced expression of -galactosidase in Vero
cells transformed with a Sindbis virus replicon cDNA under control of
the ICP8 promoter. Several Vero cell clones transformed with
pICP8SINrep/LacZ were either mock infected or infected with wild-type
HSV-1 (MOI = 10) in the presence of acyclovir in the wells of a
6-well dish. At 24 h postinfection, 2 ml of lysis buffer was added
and 10 µl of the extracts was assayed for -galactosidase activity
as described in Materials and Methods. V2-33 and V2-34 were
independently isolated transformed clones; V2-34-8 and V2-34-17 were
subclones from the original cloned V2-34 population. The results shown
are the means of results from duplicate samples.
|
|
The second method for identifying replicons was to determine if
functional SINrep/LacZ replicons could be packaged in these
cells after
they had been infected with HSV-1. We transfected
V2-33, V2-34, and
V3-45 cells with the helper plasmid, p987DHBBneo,
and then infected
them with HSV-1 or mock infected them. Thirty
hours later, cell
extracts were assayed for

-galactosidase (Fig.
3A). Samples from the
media of these Vero cell cultures were inoculated
onto BHK cells, and
18 h later

-galactosidase activity was measured
in the BHK cell
extracts (Fig.
3B). These data show that following
transfection with a
helper plasmid, HSV-1 induced the production
of infectious particles
that behaved like SINrep/LacZ particles.
We also used a slightly
different protocol, in which the Vero
cells were first infected with
HSV-1 and then were transfected
with helper plasmid or mock
transfected. Only samples of the media
from HSV-infected cultures which
had also been transfected with
helper plasmid produced infectious
particles, as shown by the

-galactosidase activity in extracts from
BHK cells (Fig.
3C).
Further support for
the idea that these cells produced Sindbis
virus replicon particles was
provided by the observation that
neutralizing antisera to Sindbis virus
were able to substantially
inhibit this activity (data not shown, but
see Fig.
5).

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 3.
Complementation of the HSV-1-induced SINrep/LacZ
replicon by a defective helper expressing the Sindbis virus structural
proteins. (A) Induction of -galactosidase activity in V2-33, V2-34,
and V3-45 Vero cell lines was dependent on infection with HSV-1. Three
independently transformed cell clones, V2-33, V2-34, and V3-45, were
plated into the wells of a 24-well dish. Subconfluent monolayers (50%
confluence) of the cells were transfected with the defective helper
cDNA plasmid, p987DHBBneo. After 72 h, the cells were either mock
infected or infected with HSV-1 at an MOI of 5 in the presence of
acyclovir. At 30 h postinfection, cell extracts (10 µl) were
assayed for -galactosidase activity as described in Materials and
Methods. (B) Production of SINrep/LacZ particles was dependent on HSV-1
infection of ICP8SINrep/LacZ-transformed Vero cell lines (V2-33, V2-34,
and V3-45). A sample (200 µl) of the medium harvested from the Vero
cell lines (assayed as described for panel A) was inoculated onto BHK
cells in the wells of a 24-well dish. At 18 h postinfection of the
BHK cells, lysis buffer (250 µl) was added to the cells and the
extracts (50 µl) were assayed for -galactosidase activity. (C)
Production of SINrep/LacZ particles was dependent on transfection of
the Vero cell lines with the defective helper plasmid. Subclones of
V2-33 and V2-34 cells were infected with HSV-1 (MOI = 10). At
5 h postinfection the cells were either transfected with the
helper plasmid p987DHBBneo or mock transfected. The media were
collected 18 h later and inoculated onto BHK cells, and 18 h
later -galactosidase activity was assayed as described for panel
B.
|
|
Isolation of a Vero cell line that produces a packaged Sindbis
virus replicon following HSV-1 infection.
Our ability to detect
packaged replicons in helper-transfected and HSV-1-infected Vero cells
led us to attempt to isolate stable cell lines that carried both the
SINrep/LacZ genome and the helper plasmid. To this end, we
transfected V3-45 cells with p987DHBBneo and selected for
neomycin-resistant colonies as described in Materials and Methods. A
cell line, designated V3-45N, that induced HSV-1-dependent
-galactosidase activity and released infectious particles into the
media was isolated. Extracts from a clone (V3-45-21) of the original
V3-45 cells and those from the V3-45N cells had the same level of
-galactosidase activity at 24 h after infection with HSV-1 in
the presence of acyclovir (Fig. 4A). As
expected, V3-45-21 cells showed only a small increase in enzyme
activity from 24 to 48 h. Although the initial MOI of HSV-1
infection was low (0.5), HSV-1 could not spread to uninfected cells
because of the presence of acyclovir, and in the absence of a packaging
helper, there would be no spread of the Sindbis virus replicon. V3-45N
cells, however, had a substantial increase in
-galactosidase
activity between 24 and 48 h, suggesting that the
lacZ-containing replicon was spreading in these cultures. We
found infectious particles (packaged replicons) in the media from
HSV-1-infected V3-45N cells but not from HSV-1-infected V3-45-21 cultures (Fig. 4B). The particles released into the media from HSV-1-infected V3-45N cells were identified as Sindbis virus replicons by their ability to be neutralized by antisera directed against Sindbis
virus but not by anti-HSV antiserum (Fig.
5).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 4.
Comparison of the Vero cell line that contains both
pICP8SINrep/LacZ and the packaging helper plasmid (V3-45N) with the
Vero cell line containing only the replicon plasmid (V3-45-21). V3-45N
cells were isolated as described in Materials and Methods. V3-45-21
cells are a subclone of the original cloned V3-45 cells.
-Galactosidase assays were performed as described in Materials and
Methods. (A) -Galactosidase activity of V3-45N and V3-45-21 cell
extracts 15, 24, and 48 h after infection with HSV-1 (MOI = 0.5). Extracts were made from the cells in the wells of a 24-well dish
by using 250 µl of lysis buffer, and 10 µl of extract was used to
assay -galactosidase activity. The data point indicated with an
asterisk (*) was obtained by diluting the sample to obtain an
OD562 reading within the linear range and multiplying the
result by the dilution factor. (B) -Galactosidase activity of BHK
cells inoculated with medium removed from V3-45N or V3-45-21 cells 15 and 24 h after infection with HSV-1. A sample of the medium (50 µl of 2 ml) was inoculated onto BHK cells in the wells of a 24-well
dish. At 18 h postinfection, the BHK cells were treated with 200 µl of lysis buffer and 10 µl of extract was assayed for
-galactosidase activity.
|
|

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 5.
Effect of Sindbis virus-neutralizing antiserum on the
-galactosidase-inducing activity in the media of HSV-1-infected
V3-45N cells. A sample (100 µl) from HSV-1-infected V3-45N cells was
incubated with neutralizing rabbit antisera to Sindbis virus (SIN Ab;
final dilution, 1:250) or with neutralizing human antisera to HSV (HSV
Ab; final dilution, 1:400) in 500 µl for 1 h at room
temperature. A sample of authentic SINrep/LacZ (titer of 2 × 108/ml) was diluted 1:1,000 and was also incubated with the
SIN antiserum. After the incubation, a 20-µl sample was used to
infect BHK cells in 12-well dishes. At 18 h postinfection, lysis
buffer (200 µl) was added and 50 µl of the extract was assayed for
-galactosidase activity as described in Materials and Methods. The
values obtained with samples not treated with antisera were designated
as 100%.
|
|
The spread of SINrep/LacZ in V3-45N cells indicated that these cells
might provide a very sensitive means for detecting HSV-1.
In
preliminary experiments, less than 10 PFU of HSV-1 led to an
eightfold
induction of

-galactosidase activity (data not
shown).
Induction of SINrep/LacZ by HSV-1 mutants.
The HSV-1-encoded
proteins ICP0 and ICP4, the products of immediate-early (alpha) genes,
are the major transactivators of the ICP8 promoter, and they have been
shown to have a synergistic effect on expression of ICP8 and other
HSV-1 early genes (5, 10, 13, 42). To provide further
evidence that SINrep/LacZ was under the control of the ICP8 promoter,
we infected V3-45N cells with either of two mutant viruses, one
containing a deletion in the gene for ICP0 (dlx3.1)
(20) and the other containing a deletion in the gene for
ICP4 (d120) (7). Both mutants induced much less
-galactosidase activity in V3-45N cells than wild-type virus (KOS)
(Fig. 6A). The infectious titers of the
SINrep/LacZ particles released from V3-45N cells in these experiments
were calculated from a standard curve (shown in the inset of Fig. 6B and described in Materials and Methods). Although the mutant viruses were able to induce infectious replicon particles, the titers were
significantly lower than those induced by wild-type virus (Fig. 6B).
These results provide evidence that the regulation of SINrep/LacZ in
these cells was similar to that of the native ICP8 gene, which requires
both ICP0 and ICP4 for maximal expression.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 6.
Induction of the Sindbis virus replicon in V3-45N cells
by HSV-1 mutants. V3-45N cells were infected with wild-type HSV-1
(KOS), dlx3.1 or d120 (MOI = 5). Wild-type
HSV-1 (KOS) and dlx3.1-infected cells were treated with
acyclovir (50 µM). At 24 h after infection, the medium (2 ml)
were collected and cell extracts were prepared. A sample of the medium
(200 µl) was inoculated onto BHK cells in the wells of a 24-well
dish. After 18 h, cell extracts were prepared with 200 µl
of lysis buffer and -Galactosidase activity was assayed as described
in Materials and Methods. (A) -Galactosidase activity of V3-45N cell
extracts. (B) Titers of SINrep/LacZ in media from V3-45N cells after
infection with wild-type HSV-1 (KOS), infection with mutant viruses
(d120 and dlx3.1), or mock infection. The titer
of SINrep/LacZ, expressed as blue-forming units (bfu), was determined
from a standard curve (see inset) generated as described in Materials
and Methods.
|
|
A mutant of HSV-1 that contains intact ICP0 and ICP4 genes should
activate the ICP8 promoter even if it is unable to replicate.
This type
of mutant is equivalent to wild-type HSV-1 in the presence
of acyclovir
and would provide another means of activating SINrep/LacZ
in the
absence of HSV-1 replication. One such mutant of HSV-1,
d21,
which has a large deletion in the ICP8 gene (
28), was able
to induce

-galactosidase in V3-45N cells to essentially the same
levels as those obtained with wild-type HSV-1 (data not shown).
We also
examined the distribution of

-galactosidase-positive
cells in both
V3-45N cells and the parental cells (V3-45-21) that
were not capable of
packaging the replicon. Three days after infection
with
d21,
under conditions in which only a small number of cells
in the monolayer
were infected, foci of blue cells were seen in
V3-45N cells, indicating
that SINrep/LacZ particles had spread
from a
d21-infected
cell to neighboring cells (Fig.
7). In
V3-45-21
cells only individual blue cells were observed. Most of these
cells looked as though they were dead or dying, as was expected
since
both
d21 and SINrep/LacZ are capable of causing cell
death.
Many of the blue cells in the V3-45N cell population retained
the appearance of viable cells. They most likely represented cells
infected by SINrep/LacZ particles released from previously
d21-induced
cells and had been infected for a shorter period
of time.

View larger version (60K):
[in this window]
[in a new window]
|
FIG. 7.
Photomicrographs of histochemically stained
d21-infected V3-45-21 (nonpackaging) and V3-45N (packaging)
cells. V3-45-21 and V3-45N cells were plated at 80% confluence in the
wells of a six-well dish. The cells were infected with HSV mutant virus
d21 (MOI = 0.001), and 3 days after infection the
monolayers were fixed and stained for -galactosidase.
|
|
A cell line with an HCMV-inducible Sindbis virus replicon.
We
wished to extend the model of induction of SINrep/LacZ by HSV-1 to
another member of the herpesvirus family, HCMV. The latter virus
replicates well only in primary human cells which cannot be used to
establish stable cell lines (23). HCMV infects mink lung
cells, and although it does not complete its replication cycle in these
cells, infected cells do express some of the immediate-early and early
genes (14). Based on our results demonstrating that HSV-1
was able to induce SINrep/LacZ without undergoing a complete replication cycle (see above), we used mink lung cells to isolate cell
lines analogous to those described for HSV-1.
We constructed a plasmid (pUL45SINrep/LacZ) in which the cDNA of
SINrep/LacZ was placed immediately downstream of and under
the
regulatory control of the HCMV promoter for the
UL45 gene,
an early gene that encodes a homolog of the HSV-1 ribonucleotide
reductase large subunit (
1,
6). As the 5' terminus of the
transcript from this gene has not been mapped, for this construct
we
estimated the start of transcription by using the apparent
TATA
sequence element. Preliminary tests with pUL45SINrep/LacZ
in
transient-transfection assays in mink lung cells showed that
HCMV-infected cells, but not uninfected cells, produced

-galactosidase
(data not shown). We cotransfected mink lung cells
with pUL45SINrep/LacZ
and pMonHygro and selected
hygromycin-resistant colonies (see
Materials and Methods). Isolated
clonal cell lines were screened
for HCMV-inducible

-galactosidase
activity. One cell line (MLUL45SINrep/LacZ)
showed many positive cells
when it was stained for

-galactosidase
activity only after infection
with HCMV. The

-galactosidase activity
induced in these cells was
significantly higher than that observed
in a control cell line
(MLUL45/LacZ) transformed with a DNA construct
in which the
lacZ gene was directly under the regulatory control
of the
UL45 promoter (Fig.
8).

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 8.
HCMV induction of -galactosidase activity in mink
lung cells transformed with pUL45SINrep/LacZ. Isolation of
MLUL45SINrep/LacZ cells and MLUL45/LacZ cells is described in Materials
and Methods. Each cell line was plated in the wells of a 24-well dish.
The cells were infected with 50 µl of HCMV (AD169 strain; titer of
106 infectious focus units/ml) in the presence of 0.1×
TurboTreat (Diagnostic Hybrids, Inc.). At 48 h after infection,
the cells were treated with 200 µl of lysis buffer and 50 µl of
extract was assayed for -galactosidase activity as described in
Materials and Methods. Results shown are the means of results from
triplicate samples.
|
|
We were unable to obtain packaged replicons from the MLUL45SINrep/LacZ
cells after transfection of the helper plasmid 987DHBBneo
as we had
done with HSV-1-infected V3-45 cells. We were not surprised
by this
result; one reason is that Sindbis virus and our standard
packaged
SINrep/LacZ replicate poorly in these cells. When mink
lung cells were
infected with Sindbis virus at a high MOI, the
yields of virus were
more than 100-fold lower than those obtained
in BHK cells (data not
shown). Other studies have shown that replicons
that produce low levels
of genomic RNA in BHK cells are packaged
much less efficiently than the
wild-type replicon (
8). In addition,
preliminary
observations suggest that interferon induction may
be contributing to
the poor growth of Sindbis virus, and this
could also affect our
attempts to package replicons directly (
34).
We used a different method to establish the presence of replicons in
the HCMV-induced MLUL45SINrep/LacZ cells. We isolated
polyadenylated RNA from HCMV-infected and mock-infected
MLUL45SINrep/LacZ
cells and then coelectroporated the RNA into BHK
cells with in
vitro-transcribed defective helper (DHEB) RNA
(
4). This is
essentially our protocol for packaging of
SINrep/LacZ transcripts,
but in this case the (putative) replicon RNA
came from MLUL45SINrep/LacZ
cells. Samples of media harvested
24 h posttransfection with RNA
isolated from MLUL45SINrep/LacZ
cells or with in vitro-synthesized
SINrep/LacZ RNA as a control were
then assayed for the presence
of packaged SINrep/LacZ particles by
inoculating naive BHK cells.
RNA obtained from the
MLUL45SINrep/LacZ cells infected with HCMV
contained SINrep/LacZ RNA
that was packaged into infectious particles
(Fig.
9). No packaged particles were detected
when the RNA came
from uninfected MLUL45SINrep/LacZ cells.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 9.
Production of SINrep/LacZ particles by using mRNA
isolated from HCMV-infected MLUL45SINrep/LacZ cells. Poly(A)-selected
RNAs were obtained from MLUL45SINrep/LacZ cells infected with HCMV or
mock infected (Materials and Methods). The RNA samples were transfected
into BHK cells by electroporation with defective helper RNA transcribed
in vitro from pDHEB (4). Several different amounts (2, 20, and 200 ng) of SINrep/LacZ RNA, transcribed in vitro, were also
electroporated into BHK cells with DHEB RNA as a positive control.
After 24 h, media from the BHK cells were collected and samples
were taken to infect naive BHK cells. Twenty-four hours later, the
cells were treated with 250 µl of lysis buffer and 50 µl of extract
was assayed for -galactosidase activity as described in Materials
and Methods.
|
|
 |
DISCUSSION |
The first goal of these studies was to determine if it was
possible to obtain cell lines in which the Sindbis virus replicon was
inducible. Most inducible systems can tolerate a certain amount of
basal transcription, either because its level is several orders of
magnitude lower than induced levels or because the level of basal
transcription does not result in detectable levels of the gene product.
If, however, the transcribed product is a replicon derived from a
cytopathic RNA virus, any intact RNA molecules that found their way to
the cytoplasm would initiate an autocatalytic cycle of RNA replication
and transcription which would result in the inhibition of host protein
synthesis and cell death. The generation of stable cell lines with an
inducible RNA replicon requires, therefore, a high degree of regulatory
stringency. We attribute our success to the use of tightly regulated
herpesvirus early promoters. Early gene expression in
herpesvirus-infected cells is dependent on certain immediate-early
genes, the products of which are transcriptional transactivators of
early genes (32). We took advantage of this herpesvirus gene
regulatory system to make cell lines in which the cDNA of the Sindbis
virus RNA replicon was transcriptionally inactive because of the
absence of any immediate-early gene products. Infection with the
herpesvirus then brought the necessary transactivators into the cell,
and a DNA-dependent transcription process initiated an RNA-to-RNA
amplification process. This system may be useful for any purpose which
requires tightly regulated, high-level foreign gene expression.
Our second goal was to explore the feasibility of using the induction
of the Sindbis virus replicon as a means of detecting and assaying DNA
viruses, specifically herpesviruses. A number of cell lines that
express a reporter gene in response to infection by a particular virus
have been described, and these cell lines have been shown to be useful
for detecting and quantifying viruses (25-27, 40). Certain
viruses, however, replicate poorly in cultured cells, and these viruses
would likely induce a weak signal from reporter cell lines. We had
speculated that induction of a Sindbis virus replicon by the
transcriptional transactivator of a poorly replicating virus could
enhance the level of reporter gene expression by causing a shift from a
state of low-level gene expression of the activating virus to a state
of high-level gene expression of the Sindbis virus replicon. This in
effect would provide an intracellular amplification of the initial
virus-induced signal. Our results show that for both HSV-1 and HCMV,
transactivation of the Sindbis virus replicon significantly enhanced
the
-galactosidase signal. The ability to package the replicon in
the HSV-1 system provided an additional amplification step by
production of infectious replicon particles which allowed intercellular
spread of the signal.
This type of signal amplification should be applicable to other
replicons and to other herpesviruses. Sindbis and other alphavirus replicons have a wide host range (21, 43), but in some cell lines, for example, the mink lung cells described here, replication is
inefficient. Replicons derived from other families of RNA viruses (18) could extend the use of this type of system to a much
wider variety of cultured cell lines. The replication of SINrep/LacZ was triggered by a mutant of HSV-1, d21, that is unable to
undergo replication and expresses only a subset of HSV-1 genes
(28). It was also triggered by HCMV in a cell line that is
able to carry out only some of the early steps in the viral replication
cycle. These results, taken together, suggest that an inducible RNA
replicon could be developed for detection of other viruses, including
ones such as human herpesvirus type 8, for which a fully permissive cell culture system does not yet exist.
 |
ACKNOWLEDGMENTS |
We thank Hong Liu for expert technical assistance and Paul
Hippenmeyer for plasmid pMonHygro. Thanks to Priscilla Schaffer for
providing us with HSV mutant viruses d21 and
dlx3.1 and to Neal DeLuca for providing d120.
Special thanks to David Knipe for sharing information about the ICP8
transcript. We are grateful to Milton Schlesinger, David Leib, and Ilya
Frolov for critical reading of the manuscript.
This work was supported by grant AI11377 from the National Institutes
of Health.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular Microbiology, Washington University School of Medicine, 660 S. Euclid Ave., St. Louis, MO 63110-1093. Phone: (314) 362-5718. Fax:
(314) 362-1232. E-mail: olivo{at}borcim.wustl.edu.
 |
REFERENCES |
| 1.
|
Bankier, A. T.,
S. Beck,
R. Bohni,
C. M. Brown,
R. Cerny,
M. S. Chee,
C. D. Hutchison,
T. Kouzarides,
J. A. Martignetti,
E. Preddie, et al.
1991.
The DNA sequence of the human cytomegalovirus genome.
DNA Sequence
2:1-12[Medline].
|
| 2.
|
Berglund, P.,
M. Sjöberg,
H. Garoff,
G. J. Atkins,
B. J. Sheahan, and P. Liljestöm.
1993.
Semliki Forest virus expression system: production of conditionally infectious recombinant particles.
Bio/Technology
11:916-920[Medline].
|
| 3.
|
Bredenbeek, P., and C. M. Rice.
1992.
Animal RNA virus expression systems.
Semin. Virol.
3:297-310.
|
| 4.
|
Bredenbeek, P. J.,
I. Frolov,
C. M. Rice, and S. Schlesinger.
1993.
Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs.
J. Virol.
67:6439-6446[Abstract/Free Full Text].
|
| 5.
|
Cai, W., and P. A. Schaffer.
1992.
Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early, and late genes in productively infected cells.
J. Virol.
66:2904-2915[Abstract/Free Full Text].
|
| 6.
|
Chee, M. S.,
A. T. Bankier,
S. Beck,
R. Bohni,
C. M. Brown,
R. Cerny,
T. Horsnell,
C. D. Hutchison,
T. Kouzarides,
J. A. Martignetti, et al.
1990.
Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.
Curr. Top. Microbiol. Immunol.
154:125-169[Medline].
|
| 7.
|
DeLuca, N. A.,
A. M. McCarthy, and P. A. Schaffer.
1985.
Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4.
J. Virol.
56:558-570[Abstract/Free Full Text].
|
| 8.
| Dryga, S., I. Frolov, and S. Schlesinger.
Unpublished results.
|
| 9.
|
Dubensky, T. W. J.,
D. A. Driver,
J. M. Polo,
B. A. Belli,
E. M. Latham,
C. E. Ibanez,
S. Chada,
D. Brumm,
T. A. Banks,
S. J. Mento,
D. J. Jolly, and S. M. W. Chang.
1996.
Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer.
J. Virol.
70:508-519[Abstract].
|
| 10.
|
Everett, R. D.
1984.
Trans-activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity.
EMBO J.
3:3135-3141[Medline].
|
| 11.
|
Frolov, I.,
T. A. Hoffman,
B. M. Pragai,
S. A. Dryga,
H. V. Huang,
S. Schlesinger, and C. M. Rice.
1996.
Alphavirus-based expression vectors: strategies and applications.
Proc. Natl. Acad. Sci. USA
93:11371-11377[Abstract/Free Full Text].
|
| 12.
|
Frolov, I., and S. Schlesinger.
1994.
Comparison of the effects of Sindbis virus and Sindbis virus replicons on host cell protein synthesis and cytopathogenicity in BHK cells.
J. Virol.
68:1721-1727[Abstract/Free Full Text].
|
| 13.
|
Gelman, I. H., and S. Silverstein.
1985.
Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene.
Proc. Natl. Acad. Sci. USA
82:5265-5269[Abstract/Free Full Text].
|
| 14.
|
Gleaves, C. A.,
T. F. Smith,
E. A. Shuster, and G. R. Pearson.
1985.
Comparison of standard tube and shell vial culture techniques for the detection of cytomegalovirus in clinical specimens.
J. Clin. Microbiol.
21:217-221[Abstract/Free Full Text].
|
| 15.
|
Hariharan, M. J.,
D. A. Driver,
K. Townsend,
D. Brumm,
J. M. Polo,
B. A. Belli,
D. J. Catton,
D. Hsu,
D. Mittelstaedt,
J. E. McCormack,
L. Karavodin,
T. W. Dubensky, Jr.,
S. M. Chang, and T. A. Banks.
1998.
DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector.
J. Virol.
72:950-958[Abstract/Free Full Text].
|
| 16.
|
Herweijer, H.,
J. S. Latendresse,
P. Williams,
G. Zhang,
I. Danko,
S. Schlesinger, and J. A. Wolff.
1995.
A plasmid-based self-amplifying Sindbis virus vector.
Hum. Gene Ther.
6:1161-1167[Medline].
|
| 17.
|
Honess, R. W., and B. Roizman.
1974.
Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins.
J. Virol.
14:8-19[Abstract/Free Full Text].
|
| 18.
|
Johnson, K. L., and L. A. Ball.
1997.
Replication of flock house virus RNAs from primary transcripts made in cells by RNA polymerase II.
J. Virol.
71:3323-3327[Abstract].
|
| 19.
|
Kääriäinen, L., and M. Ranki.
1984.
Inhibition of cell functions by RNA-virus infections.
Annu. Rev. Microbiol.
38:91-109[Medline].
|
| 20.
|
Leib, D. A.,
D. M. Coen,
C. L. Bogard,
K. A. Hicks,
D. R. Yager,
D. M. Knipe,
K. L. Tyler, and P. A. Schaffer.
1989.
Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency.
J. Virol.
63:759-768[Abstract/Free Full Text].
|
| 21.
|
Liljeström, P., and H. Garoff.
1991.
A new generation of animal cell expression vectors based on the Semliki Forest virus replicon.
Bio/Technology
9:1356-1361[Medline].
|
| 22.
|
McGeoch, D. J.,
M. A. Dalrymple,
A. J. Davison,
A. Dolan,
M. C. Frame,
D. McNab,
L. J. Perry,
J. E. Scott, and P. Taylor.
1988.
The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1.
J. Gen. Virol.
69:1531-1574[Abstract/Free Full Text].
|
| 23.
|
Mocarski, E. S., Jr.
1996.
Cytomegaloviruses and their replication, p. 2447-2492.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology. Lippincott-Raven, New York, N.Y.
|
| 24.
|
O'Hare, P., and G. S. Hayward.
1985.
Evidence for a direct role for both the 175,000- and 110,000-molecular-weight immediate-early proteins of herpes simplex virus in the transactivation of delayed-early promoters.
J. Virol.
53:751-760[Abstract/Free Full Text].
|
| 25.
|
Olivo, P. D.
1996.
Transgenic cell lines for detection of animal viruses.
Clin. Microbiol. Rev.
9:321-334[Abstract].
|
| 26.
|
Olivo, P. D.,
I. Frolov, and S. Schlesinger.
1994.
A cell line that expresses a reporter gene in response to infection by Sindbis virus: a prototype for detection of positive strand RNA viruses.
Virology
198:381-384[Medline].
|
| 27.
|
Olivo, P. D.,
M. E. Peeples,
P. L. Collins, and S. Schlesinger.
1998.
Detection and quantitation of human respiratory syncytial virus (RSV) using minigenome cDNA and a Sindbis virus replicon: a prototype assay for detecting negative-strand RNA viruses.
Virology
251:198-205[Medline].
|
| 28.
|
Orberg, P. K., and P. A. Schaffer.
1987.
Expression of herpes simplex virus type 1 major DNA-binding protein, ICP8, in transformed cell lines: complementation of deletion mutants and inhibition of wild-type virus.
J. Virol.
61:1136-1146[Abstract/Free Full Text].
|
| 29.
|
Polo, J. M., and T. W. Dubensky, Jr.
1998.
DNA vaccines with a kick.
Nat. Biotechnol.
16:517-518[Medline].
|
| 30.
|
Quinlan, M. P., and D. M. Knipe.
1985.
Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral functions.
Mol. Cell. Biol.
5:957-963[Abstract/Free Full Text].
|
| 31.
|
Quinn, J. P., and D. J. McGeoch.
1985.
DNA sequence of the region in the genome of herpes simplex virus type 1 containing the genes for DNA polymerase and the major DNA binding protein.
Nucleic Acids Res.
13:8143-8163[Abstract/Free Full Text].
|
| 32.
|
Roizman, B., and A. E. Sears.
1996.
Herpes simplex viruses and their replication, p. 2231-2295.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology. Lippincott-Raven, New York, N.Y.
|
| 33.
|
Sacks, W. R., and P. A. Schaffer.
1987.
Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture.
J. Virol.
61:829-839[Abstract/Free Full Text].
|
| 34.
| Schlesinger, S. Unpublished results.
|
| 35.
|
Schlesinger, S.
1993.
Alphaviruses vectors for the expression of heterologous genes.
Trends Biotechnol.
11:18-22[Medline].
|
| 36.
|
Schlesinger, S.
1995.
RNA viruses as vectors for the expression of heterologous proteins.
Mol. Biotechnol.
3:155-165[Medline].
|
| 37.
|
Schlesinger, S., and M. J. Schlesinger.
1996.
Togaviridae: the viruses and their replication, p. 825-841.
In
B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology. Lippincott-Raven, New York, N.Y.
|
| 38.
| Scholl, D. R. Personal communication.
|
| 39.
|
Spector, S. A.
1990.
Diagnosis of cytomegalovirus infection.
Semin. Hematol.
27:11-16.
|
| 40.
|
Stabell, E. C., and P. D. Olivo.
1992.
Isolation of a cell line for rapid and sensitive histochemical assay for the detection of herpes simplex virus.
J. Virol. Methods
38:195-204[Medline].
|
| 41.
|
Strauss, J. H., and E. G. Strauss.
1994.
The alphaviruses: gene expression, replication, and evolution.
Microbiol. Rev.
58:491-562[Abstract/Free Full Text].
|
| 42.
|
Su, L., and D. M. Knipe.
1987.
Mapping the transcriptional initiation site of the herpes simplex virus type 1 ICP8 gene in infected and transfected cells.
J. Virol.
61:615-620[Abstract/Free Full Text].
|
| 43.
|
Xiong, C.,
R. Levis,
P. Shen,
S. Schlesinger,
C. M. Rice, and H. V. Huang.
1989.
Sindbis virus: an efficient, broad host range vector for gene expression in animal cells.
Science
243:1188-1191[Abstract/Free Full Text].
|
Journal of Virology, March 1999, p. 1998-2005, Vol. 73, No. 3
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Reap, E. A., Dryga, S. A., Morris, J., Rivers, B., Norberg, P. K., Olmsted, R. A., Chulay, J. D.
(2007). Cellular and Humoral Immune Responses to Alphavirus Replicon Vaccines Expressing Cytomegalovirus pp65, IE1, and gB Proteins. CVI
14: 748-755
[Abstract]
[Full Text]